Therapeutical interventions in allergic diseases such as allergen-induced asthma specifically targeting IL-4, IL-5 or IL-13 cytokines caused none to moderate improvement regarding disease severity and symptoms[41]. The gene discussed is IL5; the disease is allergic disease.